Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Akros Pharma Inc.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Have type 2 diabetes;
2. Body mass index (BMI) of ≤ 45.0 kg/m2;
3. Are either untreated with respect to hypoglycemic agents OR are currently being treated with a stable dose of metformin alone.
You may not be if
1. Females who are pregnant or breast-feeding;
2. Known medical history or presence of type 1 diabetes or pancreatitis, acute metabolic diabetic complications, presence of unstable or rapidly progressing retinopathy, nephropathy or neuropathy;
3. Acute coronary syndrome or uncontrolled hypertension;
4. Does not meet all diet or previous/concomitant medication restrictions criteria, as described in the protocol.
Clareo Health | Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients
